Key result
Diabetic patients with asymptomatic coronary artery disease had significantly higher cardiac mortality than those with symptomatic disease (26% vs. 9%; P<0.001).
Why the study?
Does asymptomatic CAD compared to symptomatic CAD affect MACE and cardiac mortality in diabetic patients?
Cohort (n=310)
Does asymptomatic CAD compared to symptomatic CAD affect MACE and cardiac mortality in diabetic patients?
Absolute Event Rate: 26% vs 9%
p-value: p=<0.001
Diabetic patients with asymptomatic CAD have higher cardiac mortality than those with symptomatic CAD, potentially due to underutilization of early revascularization therapy.
Asymptomatic CAD linked to higher cardiac mortality in diabetes; leaves open whether targeted screening or intervention improves outcomes.
AIMS: Information on the clinical outcome of patients with diabetes with silent myocardial ischaemia is limited. We compared the clinical and angiographic characteristics, and the clinical outcomes of diabetic patients with asymptomatic or symptomatic coronary artery disease (CAD). METHODS: Three hundred and ten consecutive diabetic patients with CAD were divided into two groups according to the presence of angina and followed for a mean of 5 years. Fifty-six asymptomatic patients with a positive stress test and CAD on coronary angiography were compared with 254 symptomatic patients, 167 with unstable angina and 87 with chronic stable angina. RESULTS: Although the severity of coronary atherosclerosis was similar in asymptomatic and symptomatic patients, revascularization therapy was performed less frequently in the asymptomatic than the symptomatic patients (26.8 vs. 62.0%; P < 0.001). Asymptomatic patients experienced a similar number of major adverse cardiac events (MACEs; death, non-fatal myocardial infarction, and revascularization; 32 vs. 28%; P = 0.57), but had higher cardiac mortality than symptomatic patients (26 vs. 9%; P < 0.001). However, patients who underwent revascularization therapy at the time of CAD diagnosis in these two groups showed similar MACE and cardiac mortality (20.0 vs. 22.5%, 6.7 vs. 5.3%, respectively; all P > 0.05). CONCLUSIONS: This study suggests that diabetic patients with asymptomatic CAD have a higher cardiac mortality risk than those with symptomatic CAD, and that lack of revascularization therapy may be responsible for the poorer survival.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2007) conducted a cohort in Diabetes with coronary artery disease (n=310). Asymptomatic coronary artery disease vs. Symptomatic coronary artery disease was evaluated on Cardiac mortality (p=<0.001). Diabetic patients with asymptomatic coronary artery disease had significantly higher cardiac mortality than those with symptomatic disease (26% vs. 9%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: